金属复合物和衍生材料的制药应用
1Núcleo de Desenvolvimento de Compostos Bioativos (NDCBio), Universidade Federal do Triângulo Mineiro, Av. Dr. Randolfo Borges 1400, Uberaba 38025-440, MG, Brazil.
Pharmaceutics
|November 27, 2025
概括
药用无机化学利用金属复合物用于各种制药用途,包括治疗和诊断. 这一领域对开发先进的医疗治疗有显著的前景.
科学领域:
- 药用无机化学 药用无机化学
- 材料科学 材料科学 材料科学
- 药物应用 药物应用
背景情况:
- 药用无机化学是一个快速增长的领域.
- 金属复合物为医疗应用提供独特的特性.
研究的目的:
- 探索金属复合体在制药应用中的潜力.
- 突出这些材料的治疗,诊断和治疗术的用途.
主要方法:
- 新型金属复合物的设计和开发.
- 材料属性的表征.
- 药物疗效的评估. 药物疗效的评估.
主要成果:
- 证明金属复合物的治疗应用的潜力.
- 成功开发诊断剂. 诊断剂的成功开发.
- 在光学材料设计的进步.
结论:
- 药用无机化学为制药创新提供了一个强大的平台.
- 金属复合体是现代医学的多功能工具.
- 这一领域的进一步研究有望带来显著的临床益处.
相关概念视频
Metal-Ligand Bonds
23.9K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
23.9K
Extraction: Advanced Methods
1.1K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.1K
Complexation Equilibria: Factors Influencing Stability of Complexes
774
In complexation reactions, metal cations are the electron pair acceptors, and the ligands are the electron pair donors. The stability of the metal complexes depends primarily on the complexing ability of the central metal ion and the nature of the ligands. Generally, the complexing ability of the metal ion depends on the size and charge of the ion. As the metal ion size increases, the stability of the metal complexes decreases, provided that the valency of the metal ion and the ligands remain...
774
Complexation Equilibria: The Chelate Effect
1.2K
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
1.2K
Complexometric Titration: Ligands
2.2K
Different monodentate and polydentate ligands are used as complexing agents in complexometric titration reactions. The formation of complexes by mono- and bidentate ligands involves two or more intermediate steps, limiting their use as complexing agents. In comparison, polydentate ligands can form complexes with metal ions in a single-step process, facilitating sharper end points. This means polydentate ligands, such as amino carboxylic acid derivatives, are most commonly employed in...
2.2K
EDTA: Chemistry and Properties
3.2K
Polydentate ligands are most widely used in complexometric titrations because they form more stable complexes with the metal ions than mono- or bidentate ligands due to the chelate effect. Examples of polydentate ligands are ethylenediaminetetraacetic acid (EDTA), crown ethers, and cryptands. The most important feature of optimal polydentate ligands is the ability to form 1:1 complexes in a single-step process. Amino carboxylic acid derivatives are frequently used as complexing agents. EDTA is...
3.2K


